Cite
HARVARD Citation
Vellas, B. et al. (2013). Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force. Alzheimer's & dementia. 9 (4), pp. 438-444. [Online].